Circulating cell-free miRNAs as biomarker for triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer in women globally. This subtype often has early and high recurrence rates resulting in poor survival, partially due to lack of targeted therapies. Therefore, there is an urgent need to identify TNBC-specific bi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Cancer
Asıl Yazarlar: Shin, V Y, Siu, J M, Cheuk, I, Ng, E K O, Kwong, A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2015
Konular:
Molecular Diagnostics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4647231/
https://ncbi.nlm.nih.gov/pubmed/25906045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.143
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller